Floatz logo

OBI 3424

T-Lymphoblastic Lymphoma

SWOG Cancer Research NetworkSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

45 Active assets in the T-Lymphoblastic Lymphoma cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
METHOTREXATE
Children's Oncology Group
Phase 3BB
PEGASPARGASE
Children's Oncology Group
Phase 3BB
ASPARAGINASE
University of Washington
Phase 3BB
Cyclophosphamide
Children's Oncology Group
Phase 3BB

View all 50 →

Same molecule, other indications

OBI 3424 is also rated in:

hepatocellular carcinomaDormant
B
Indicative ·
58 / 100
View asset →
T-cell acute lymphoblastic leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
refractory precursor T-lymphoblastic lymphoma/leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →